Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.
Biotech companyLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field. in United StatesLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field.. FDA records under its name, each linked to the record.
As of Nov 14, 2026, FDA's public records list Mirum Pharmaceuticals with 5 drug applications.
Drug applications: 5
Records by Year
Drug approvals, 510(k) clearances, recalls and letters, 2017 to 2026 to date
How to read this
A hatched bar is a year that is not over, so its count covers only part of the year.
02017Records0
020182018Records0vs 2017+0
02019Records0vs 2018+0
020202020Records0vs 2019+0
12021Records1vs 2020+1
020222022Records0vs 2021−1
02023Records0vs 2022+0
020242024Records0vs 2023+0
22025Records2vs 2024+2
120262026 to dateRecords1
Latest Records
Newest first across sources; each opens the record
FDA's databases did not answer. Reload in a moment.
LivmarliTreatment of alagille syndrome · Sep 4, 2013 · approved Mar 13, 2023
Medicines Authorised in the EU (EMA)
One medicine, 1 of them new active substances, matched by the authorisation holder's name; see all EU approvals
LivmarliNew substance · maralixibat chloride · Dec 9, 2022
Names and Identifiers
Appears as
MIRUM
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata.How this page is built
